The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Advance in research of anti-HCV drugs and therapies
Author(s): 
Pages: 2624-2630
Year: Issue:  22
Journal: Chinese Journal of New Drugs

Keyword:  hepatitis C viruscombination therapytrend of development;
Abstract: Hepatitis C virus can be divided to 6 genotypes and 70 subtypes. Due to no immunity and repeated infection,hepatitis C is a serious viral infectious disease to human health and very difficult to prevent. The use of interferon and ribavirin is still the main combination therapy to treat hepatitis C. In this paper,the types of anti-hepatitis C drug treatment,the development trends and market prospects were systematically summarized,to provide reference for the development of the new anti-HCV drugs.
Related Articles
loading...